Search For

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Is liver fibrosis a risk factor for gynecological cancers?

Non-metabolic causes of steatotic liver disease

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Ultrasonographic fatty liver indicator (US-FLI): a reliable biomarker for non-invasive NAFLD stratification

The bidirectional relationship between fatty liver disease and COVID-19

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms